Techline Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Techline Technologies's estimated annual revenue is currently $1.7M per year.
- Techline Technologies's estimated revenue per employee is $60,714
Employee Data
- Techline Technologies has 28 Employees.
- Techline Technologies grew their employee count by -3% last year.
Techline Technologies's People
Name | Title | Email/Phone |
---|
Techline Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 220 | 0% | N/A | N/A |
#2 | $15M | 286 | 6% | N/A | N/A |
#3 | N/A | 38 | 9% | N/A | N/A |
#4 | N/A | 33 | 10% | N/A | N/A |
#5 | $3.5M | 43 | 5% | N/A | N/A |
#6 | N/A | 33 | 6% | N/A | N/A |
#7 | N/A | 43 | 23% | N/A | N/A |
#8 | $3.5M | 38 | 12% | N/A | N/A |
#9 | $35M | 38 | -3% | N/A | N/A |
#10 | $15M | 50 | -9% | N/A | N/A |
What Is Techline Technologies?
Techline Technologies, Inc. in Willow Grove, Pennsylvania, offers trauma simulation equipment to help in the training process of medical responders. Our inventory includes moulage supplies, as well as medical manikins. Furthermore, we are a women-owned, small company, with more than 10 years in business. Our clientele base includes military personnel, law enforcement, and EMS teams. Trauma produces realistic, wearable wound simulations, trauma manikins, and part task trainers that provide years of service. The quick donning and doffing of the wounds, without makeup or adhesives, maximizes your training time. The depth of the wounds allows trainees to practice hemorrhage control skills beyond simple bandaging.
keywords:N/AN/A
Total Funding
28
Number of Employees
$1.7M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 28 | -15% | N/A |
#2 | $7.2M | 29 | 0% | N/A |
#3 | $9M | 32 | 7% | N/A |
#4 | $5.6M | 32 | 3% | N/A |
#5 | $7.4M | 32 | 3% | N/A |